PD-L1 and NOS2 expression in both tumor and DCs were induced by the sustained IFN-β transcription, and NOS2 inhibition maintained long-term control of tumors with anti-PD-1 treatment [114]. This evidence concerns the gene IFNB1 and neoplasm.